PolyMedix Outlines Potential Benefits of GAIN Act to Its Antibiotic Development Program – msnbc.com

July 13, 2012 Posted By: Leave a comment
Signed into law this week, the GAIN Act provides incentives for ... About PolyMedix, Inc. PolyMedix is a clinical stage biotechnology company developing a novel class of antimicrobial agents – cidins, small-molecule mimetics of host-defense ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>